Regenerative therapies for diabetic microangiopathy

Area of Science:

• Cardiovascular Science
• Endocrinology
• Regenerative Medicine

Background:

• Hyperglycemia in diabetes mellitus accelerates arterial remodeling and atherosclerosis, impacting both macro- and microcirculation.
• Vessel injury mechanisms include disrupted glucose homeostasis, advanced glycation end-product formation, reduced nitric oxide synthesis, and oxidative/reductive stress.
• Pathological changes occur extracellularly (e.g., calcium deposition) and intracellularly (e.g., pathway abnormalities, cell death).

Purpose of the Study:

• To provide a comprehensive review of regenerative therapies for diabetic microangiopathy.
• To discuss current and emerging treatment strategies for diabetes-related vascular complications.

Main Methods:

• Literature review of pharmacological therapies, growth factor administration, and stem cell strategies.
• Analysis of mechanisms underlying hyperglycemia-induced vascular damage in diabetes.

Main Results:

• Peripheral arterial disease, coronary heart disease, and ischemic stroke are major causes of morbidity and mortality in diabetic patients.
• Regenerative approaches target extracellular and intracellular damage pathways.
• Pharmacological, growth factor, and stem cell therapies show potential in managing diabetic vascular complications.

Conclusions:

• Diabetic microangiopathy is a significant clinical and economic burden.
• Regenerative therapies represent a promising frontier for treating diabetes-related vascular complications.
• Further research into these therapies is crucial for improving patient outcomes.